Sankey It
Loading...
Eli Lilly and Company Q2 FY2026 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company Q2 FY2026 income statement
USD · quarter ended 2026-06-30
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company Q2 FY2026 income statement
Flow diagram with 7 nodes and 6 flows for Eli Lilly and Company Q2 FY2026 income statement. Values: Revenue US$23B, Cost of Revenue US$3.3B, Gross Profit US$19.7B, Operating Expenses US$10.7B, Operating Income US$9B, Tax US$2.2B, Net Income US$7.1B.
Revenue
US$23B
+48% Y/Y
Cost of Revenue
(US$3.3B)
+34% Y/Y
14% of revenue
Gross Profit
US$19.7B
+50% Y/Y
86% margin
Operating Expenses
(US$10.7B)
+79% Y/Y
47% of revenue
Operating Income
US$9B
+26% Y/Y
39% margin
Tax
(US$2.2B)
+93% Y/Y
9% of revenue
Net Income
US$7.1B
+25% Y/Y
31% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen